 |
 |
|
|
RESÚMENES NOVIEMBRE 2006 |
Addictive Disorders
(Haga un click en la información del journal para acceder al resúmen)
A Randomized
Controlled Trial of a Smoking Cessation Intervention Among People With a
Psychotic Disorder
Amanda Baker, Robyn Richmond, Melanie Haile, Terry J. Lewin, Vaughan J.
Carr, Rachel L. Taylor, Sylvia Jansons, and Kay Wilhelm
American Journal of Psychiatry 163:1934-1942,
November 2006
Naltrexone with or without fluoxetine for
preventing relapse to heroin addiction in St. Petersburg, Russia
Evgeny M.
Krupitsky, Edwin E. Zvartau, Dimitry V. Masalov, Marina V. Tsoy, Andrey M.
Burakov, Valentina Y. Egorova, Tatyana Y. Didenko, Tatyana N. Romanova, Eva B.
Ivanova, Anton Y. Bespalov, Elena V. Verbitskaya, Nikolai G. Neznanov, Alexandr
Y. Grinenko, Charles P. O'Brien and George E. Woody
Journal
of Substance Abuse Treatment. Volume 31, Issue 4, December 2006, Pages 319-328
A 12-month controlled trial of methadone
medical maintenance integrated into an adaptive treatment model
Van L. King,
Michael S. Kidorf, Kenneth B. Stoller, Robert Schwartz, Kenneth Kolodner and
Robert K. Brooner
Journal
of Substance Abuse Treatment. Volume 31, Issue 4, December 2006, Pages 385-393
A 5-year evaluation of a methadone medical
maintenance program
Kenneth A. Harris,
Jr, Julia H. Arnsten, Herman Joseph, Joe Hecht, Ira Marion, Patti Juliana and
Marc N. Gourevitch
Journal
of Substance Abuse Treatment. Volume 31, Issue 4, December 2006, Pages 433-438
Systemic administration of a dopamine, but
not a serotonin or norepinephrine, transporter inhibitor reinstates cocaine
seeking in the rat
Heath D. Schmidt
and R. Christopher Pierce
Behavioural
Brain Research. Volume
175, Issue 1, 25 November 2006, Pages 189-194
The ‘meth’
epidemic: Managing acute psychosis, agitation, and suicide risk
Curr Psychiatry. Vol. 5, No. 11 / November 2006
Randomized, placebo-controlled trial of
baclofen and gabapentin for the treatment of methamphetamine dependence
Keith G.
Heinzerling, Steven Shoptaw, James A. Peck, Xiaowei Yang, Juanmei Liu, John
Roll and Walter Ling
Drug and Alcohol Dependence. Volume 85, Issue 3, 1
December 2006, Pages 177-184
Double-blind, placebo-controlled trial of
selegiline transdermal system (STS) for the treatment of cocaine dependence
Ahmed Elkashef,
Paul J. Fudala, Liza Gorgon, Shou-Hua Li, Roberta Kahn, Nora Chiang, Frank
Vocci, Joseph Collins, Karen Jones, Kathy Boardman and Mike Sather
Drug and Alcohol Dependence. Volume 85, Issue 3, 1
December 2006, Pages 191-197
The relationship between crystalline
methamphetamine use and methamphetamine dependence
Rebecca McKetin, Erin Kelly and Jennifer McLaren
Drug and Alcohol Dependence. Volume 85, Issue 3, 1
December 2006, Pages 198-204
Low bone density in patients receiving
methadone maintenance treatment
Theresa W. Kim,
Daniel P. Alford, Alan Malabanan, Michael F. Holick and Jeffrey H. Samet
Drug and Alcohol Dependence. Volume 85, Issue 3, 1 December 2006, Pages 258-262
Changes in
alcohol craving and consumption by phase of menstrual cycle in alcohol
dependent women
E. E. Epstein, K. C. Rhines, S. Cook, B.
Zdep Mattocks, N.
K. Jensen, B. S. Mccrady
Journal of Substance Use. Volume 11, Number 5 /
October 2006: 323 - 332
Substance abuse treatment entry, retention,
and outcome in women: A review of the literature
Shelly F.
Greenfield, Audrey J. Brooks, Susan M. Gordon, Carla A. Green, Frankie Kropp,
R. Kathryn McHugh, Melissa Lincoln, Denise Hien and Gloria M. Miele
Drug and Alcohol Dependence. Volume 86, Issue 1, 5
January 2007, Pages 1-21
Oral delta-9-tetrahydrocannabinol suppresses
cannabis withdrawal symptoms
Alan J. Budney,
Ryan G. Vandrey, John R. Hughes, Brent A. Moore and Betsy Bahrenburg
Drug and Alcohol Dependence. Volume 86, Issue 1, 5
January 2007, Pages 22-29
One session of high frequency repetitive
transcranial magnetic stimulation (rTMS) to the right prefrontal cortex
transiently reduces cocaine craving
Joan Albert
Camprodon, José Martínez-Raga, Miguel Alonso-Alonso, Mei-Chiung Shih and Alvaro
Pascual-Leone
Drug and Alcohol Dependence. Volume 86, Issue 1, 5
January 2007, Pages 91-94
Remission of Psychiatric
Symptoms Among Drug Misusers After Drug Dependence Treatment
Gossop,
Michael; Marsden, John; Stewart,
Journal of Nervous & Mental Disease.
194(11):826-832, November 2006
Gamma-Hydroxybutyrate (GHB) in Humans. Pharmacodynamics and Pharmacokinetics
SERGIO
ABANADES, MAGI FARRÉ, MIREIA SEGURA, SIMONA PICHINI, DIEGO BARRAL, ROBERTA
PACIFICI, MANUELA PELLEGRINI, FRANCINA FONSECA, KLAUS LANGOHR AND RAFAEL DE LA
TORRE
Ann.
N.Y. Acad. Sci. 1074: 559–576 (2006)
Persistent and Reversible Morphine
Withdrawal-Induced Morphological Changes in the Nucleus Accumbens
MARCO DIANA,
SATURNINO SPIGA AND ELIO ACQUAS
Ann. N.Y. Acad. Sci. 1074: 446–457 (2006)
Fluoxetine as a Potential
Pharmacotherapy for Methamphetamine Dependence. Studies in Mice
YUKIO
TAKAMATSU, HIDEKO YAMAMOTO, YASUKAZU OGAI, YOKO HAGINO, ATHINA MARKOU AND
KAZUTAKA IKEDA
Ann. N.Y. Acad. Sci. 1074: 295–302 (2006)
Estrogen, Testosterone,
and Methamphetamine Toxicity
DEAN E
DLUZEN AND JANET L MCDERMOTT
Ann. N.Y. Acad. Sci. 1074: 282–294 (2006)
Protection by GDNF and Other
Trophic Factors Against the Dopamine-Depleting Effects of Neurotoxic Doses of
Methamphetamine
WAYNE A CASS, LAURA E PETERS,
MICHAEL E HARNED AND KIM B SEROOGY
Ann.
N.Y. Acad. Sci. 1074: 272–281 (2006)
Calcitriol Protects against the
Dopamine- and Serotonin-Depleting Effects of Neurotoxic Doses of
Methamphetamine
WAYNE A CASS, MICHAEL P SMITH AND
LAURA E PETERS
Ann.
N.Y. Acad. Sci. 1074: 261–271 (2006)
Balance between Dopamine and
Serotonin Release Modulates Behavioral Effects of Amphetamine-Type Drugs
RICHARD B ROTHMAN AND MICHAEL H
BAUMANN
Ann.
N.Y. Acad. Sci. 1074: 245–260 (2006)
Longitudinal Clinical Course
Following Pharmacological Treatment of Methamphetamine Psychosis Which Persists
after Long-Term Abstinence
KAZUFUMI AKIYAMA
Ann.
N.Y. Acad. Sci. 1074: 125–134 (2006)
Genes and Gene Expression in the
Brains of Human Alcoholics
PETER R DODD, S. TRACEY BUCKLEY,
ALLISON L ECKERT, PHILOMENA F FOLEY AND DAVID J INNES
Ann. N.Y. Acad. Sci. 1074: 104–115 (2006)
Treatment of polydrug-using opiate dependents during
withdrawal: towards a standardisation of treatment
BMC Psychiatry 2006, 6:54
Dual dopamine–5-HT releasers: potential
treatment agents for cocaine addiction
Richard B.
Rothman, Bruce E. Blough, and Michael H. Baumann
Trends
in Pharmacological Sciences. Volume 27, Issue 12, December 2006, Pages 612-618
The Status of Naltrexone in
the Treatment of Alcohol Dependence: Specific Effects on Heavy Drinking
Pettinati,
Helen M; O'Brien, Charles P; Rabinowitz, Amanda R; Wortman, Shoshana P; Oslin,
David W; Kampman, Kyle M; Dackis, Charles A
Journal of Clinical Psychopharmacology. 26(6):610-625,
December 2006
One-year Mortality Rates of
Patients Receiving Methadone and Buprenorphine Maintenance Therapy: A
Nationally Representative Cohort Study in 2694 Patients
Soyka,
Michael; Apelt, Sabine; Lieb, Martin; Wittchen, Hans-Ulrich
Journal of Clinical Psychopharmacology. 26(6):657-660,
December 2006
Loss
of Serotonin Transporter Protein after MDMA and Other Ring-Substituted
Amphetamines
Tao Xie,
Liqiong Tong, Michael W McLane, George Hatzidimitriou,
Jie Yuan, Una McCann and George Ricaurte
Neuropsychopharmacology (2006) 31,
2639–2651
Increased
Occupancy of Dopamine Receptors in Human Striatum during Cue-Elicited Cocaine
Craving
Dean F Wong,
Hiroto Kuwabara, David J Schretlen, Katherine R Bonson,
Yun Zhou, Ayon Nandi, James R Brasic, Alane S Kimes, Marika
A Maris, Anil Kumar, Carlo Contoreggi, Jonathan Links,
Monique Ernst, Olivier Rousset, Stephen Zukin, Anthony
A Grace, Charles Rohde, Donald R Jasinski, Albert Gjedde
and Edythe D London
Neuropsychopharmacology (2006) 31,
2716–2727
Effects
of Expectancy and Abstinence on the Neural Response to Smoking Cues in
Cigarette Smokers: an fMRI Study
Dharma McBride,
Sean P Barrett, Jared T Kelly, Andrew Aw and Alain Dagher
Neuropsychopharmacology (2006) 31,
2728–2738
Naltrexone with or without
fluoxetine for preventing relapse to heroin addiction in
Evgeny M. Krupitsky, Edwin
E. Zvartau, Dimitry
V. Masalov, Marina
V. Tsoy, Andrey
M. Burakov, Valentina
Y. Egorova, Tatyana
Y. Didenko, Tatyana
N. Romanova, Eva B. Ivanova, Anton
Y. Bespalov, Elena
V. Verbitskaya, Nikolai
G. Neznanov, Alexandr
Y. Grinenko, Charles P. O'Brien, George E. Woody
J
Subs Abuse Treatment Volume 31, Issue 4, Pages 319-328 (December 2006)
A 12-month controlled trial of
methadone medical maintenance integrated into an adaptive treatment model
Van L. King, Michael S. Kidorf, Kenneth B. Stoller, Robert Schwartz, Kenneth Kolodner, Robert K. Brooner
J
Subs Abuse Treatment. Volume 31, Issue 4, Pages 385-393 (December 2006)
A 5-year evaluation of a
methadone medical maintenance program
Kenneth A. Harris Jr,
Julia
H. Arnsten, Herman Joseph, Joe Hecht, Ira Marion, Patti Juliana, Marc N. Gourevitch
J
Subs Abuse Treatment. Volume 31, Issue 4, Pages 433-438 (December 2006)
Current and Future Drug
Therapies for Alcohol Dependence. Improving Outcomes in Alcohol Dependence
Treatment
Rosenthal,
Richard N
Journal of Clinical Psychopharmacology. 26(6)
Supplement 1:S20-S29, December 2006
Combining Psychosocial
Treatment with Pharmacotherapy for Alcohol Dependence. Improving Outcomes in Alcohol
Dependence Treatment
Weiss,
Roger D; Kueppenbender, Karsten D
Journal
of Clinical Psychopharmacology. 26(6) Supplement 1:S37-S42, December 2006
CSF monoamine metabolites and lethality of
suicide attempts in depressed patients with alcohol dependence
Leo Sher, Maria A.
Oquendo, Michael F. Grunebaum, Ainsley K. Burke, Yung-yu Huang and J. John Mann
European Neuropsychopharmacology. Volume 17, Issue 1, 1
January 2007, Pages 12-15
Aripiprazole as a
Potential Pharmacotherapy for Stimulant Dependence: Human Laboratory Studies
With d-Amphetamine
Stoops, William W.
Experimental
and Clinical Psychopharmacology. 2006 Nov Vol 14(4) 413-421
Global use of
alcohol, drugs and tobacco
Anderson
P
Drug Alcohol Rev 2006;25:489 – 502
Global burden
of disease from alcohol, illicit drugs and tobacco
Rehm J, Taylor B, Room R
Drug
Alcohol Rev 2006;25:503 – 513
Mental health
and alcohol, drugs and tobacco: a review of the comorbidity between mental
disorders and the use of alcohol, tobacco and illicit drugs
Jané-Llopis
E, Matytsina I
Drug Alcohol Rev 2006;25:515 – 536
The global
economic burden of alcohol: a review and some suggestions
Baumberg B
Drug Alcohol Rev 2006;25:537 – 551
Perspectives on
Current Directions in the Neurobiology of Addiction Disorders Relevant to
Genetic Risk Factors
Yasmin L. Hurd
CNS Spectr.
2006;11(11)855-862
Neurorobiology and
Evidence-Based Biological Treatments for Substance Abuse Disorders
Iliyan S. Ivanov,
Kurt P. Schulz, Robyn C. Palmero, and Jeffrey H. Newcorn